These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 17130583)

  • 21. Islet cell transplantation as a cure for insulin dependent diabetes: current improvements in preserving islet cell mass and function.
    Fontaine MJ; Fan W
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):170-9. PubMed ID: 14599964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is islet transplantation ready for widespread use in diabetes?
    Wang J; Wang QH; Xia T; Tan JM
    Chin Med J (Engl); 2011 Mar; 124(6):935-8. PubMed ID: 21518606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Islet transplantation: where do we stand now?
    Hirshberg B; Rother KI; Harlan DM
    Diabetes Metab Res Rev; 2003; 19(3):175-8; discussion 175. PubMed ID: 12789649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective and challenges of islet transplantation for the therapy of autoimmune diabetes.
    Balamurugan AN; Bottino R; Giannoukakis N; Smetanka C
    Pancreas; 2006 Apr; 32(3):231-43. PubMed ID: 16628077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Islet transplantation, stem cells, and transfusion medicine.
    Lögdberg L; Sgan SL; Larsen CP; Hillyer CD
    Transfus Med Rev; 2003 Apr; 17(2):95-109. PubMed ID: 12733103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 6: Patient selection for pilot clinical trials of islet xenotransplantation.
    O'Connell PJ
    Xenotransplantation; 2009; 16(4):249-54. PubMed ID: 19799765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving islet transplantation: a road map for a widespread application for the cure of persons with type I diabetes.
    Korsgren O; Nilsson B
    Curr Opin Organ Transplant; 2009 Dec; 14(6):683-7. PubMed ID: 19779341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Technique of pancreatic procurement for pancreatic islet isolation].
    Hubert T; Arnalsteen L; Jany T; Prieur E; Triponez F; Nunes B; Vantyghem MC; Gmyr V; Kerr-Conte J; Proye C; Pattou F
    Ann Chir; 2005; 130(6-7):384-90. PubMed ID: 16023459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Islet cell transplantation.
    Vaithilingam V; Sundaram G; Tuch BE
    Curr Opin Organ Transplant; 2008 Dec; 13(6):633-8. PubMed ID: 19060555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allosensitization of islet allograft recipients.
    Cardani R; Pileggi A; Ricordi C; Gomez C; Baidal DA; Ponte GG; Mineo D; Faradji RN; Froud T; Ciancio G; Esquenazi V; Burke GW; Selvaggi G; Miller J; Kenyon NS; Alejandro R
    Transplantation; 2007 Dec; 84(11):1413-27. PubMed ID: 18091517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current indications for pancreas or islet transplant.
    Ryan EA; Bigam D; Shapiro AM
    Diabetes Obes Metab; 2006 Jan; 8(1):1-7. PubMed ID: 16367876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-CD20 treatment prolongs syngeneic islet graft survival and delays the onset of recurrent autoimmune diabetes.
    Hu C; Deng S; Wong FS; Wen L
    Ann N Y Acad Sci; 2008 Dec; 1150():217-9. PubMed ID: 19120299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Islet transplantation: progress and challenge.
    Gaglia JL; Shapiro AM; Weir GC
    Arch Med Res; 2005; 36(3):273-80. PubMed ID: 15925017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes.
    Ghofaili KA; Fung M; Ao Z; Meloche M; Shapiro RJ; Warnock GL; Elahi D; Meneilly GS; Thompson DM
    Transplantation; 2007 Jan; 83(1):24-8. PubMed ID: 17220786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of systemic immunosuppression on islet engraftment and function into a subcutaneous biocompatible device.
    Marzorati S; Bocca N; Molano RD; Hogan AR; Doni M; Cobianchi L; Inverardi L; Ricordi C; Pileggi A
    Transplant Proc; 2009; 41(1):352-3. PubMed ID: 19249555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia.
    Solari MG; Srinivasan S; Boumaza I; Unadkat J; Harb G; Garcia-Ocana A; Feili-Hariri M
    J Autoimmun; 2009 Mar; 32(2):116-24. PubMed ID: 19217258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic islet transplantation.
    Marzorati S; Pileggi A; Ricordi C
    Expert Opin Biol Ther; 2007 Nov; 7(11):1627-45. PubMed ID: 17961088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-cell replacement for type I diabetes.
    Stock PG; Bluestone JA
    Annu Rev Med; 2004; 55():133-56. PubMed ID: 14746513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful islet after kidney transplantations in a distance over 1000 kilometres: Preliminary results of the Budapest-Geneva collaboration.
    Langer RM; Máthé Z; Doros A; Máthé ZS; Weszelits V; Filó A; Bucher P; Morel P; Berney T; Járay J
    Transplant Proc; 2004 Dec; 36(10):3113-5. PubMed ID: 15686708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreas and islet cell transplantation in diabetes.
    Pavlakis M; Khwaja K
    Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):146-50. PubMed ID: 17940433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.